{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:16:06Z","timestamp":1773375366325,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/dote\/doy042","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T11:50:03Z","timestamp":1528113003000},"source":"Crossref","is-referenced-by-count":4,"title":["Do recent reports about the adverse effects of proton pump inhibitors change providers\u2019 prescription practice?"],"prefix":"10.1093","volume":"31","author":[{"given":"M T","family":"Al-Qaisi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1685-0865","authenticated-orcid":false,"given":"A","family":"Kahn","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M D","family":"Crowell","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G E","family":"Burdick","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M F","family":"Vela","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F C","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"key\n\t\t\t\t2018120500133927700_bib1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJM198812293192605","article-title":"The physiology of gastric acid secretion","volume":"319","author":"Wolfe","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018120500133927700_bib2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018120500133927700_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018120500133927700_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018120500133927700_bib5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.1994.03510420061035","article-title":"Zollinger-Ellison Syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma","volume":"271","author":"Jensen","year":"1994","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018120500133927700_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1542-3565(04)00606-8","article-title":"Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study","volume":"3","author":"Hirschowitz","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018120500133927700_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0002-9610(85)80031-3","article-title":"Barrett's esophagus: Its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux","volume":"149","author":"Sarr","year":"1985","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t2018120500133927700_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2003.09.030","article-title":"Screening for Barrett's esophagus in colonoscopy patients with and without heartburn","volume":"125","author":"Rex","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018120500133927700_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","article-title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel","volume":"180","author":"Juurlink","year":"2009","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t2018120500133927700_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018120500133927700_bib11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials","volume":"374","author":"O\u2019Donoghue","year":"2009","journal-title":"Lancet North Am Ed"},{"key":"key\n\t\t\t\t2018120500133927700_bib12","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2010.09.010","article-title":"ACCF\/ACG\/ AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"56","author":"Abraham","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2018120500133927700_bib13","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018120500133927700_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures","volume":"179","author":"Targownik","year":"2008","journal-title":"Can Med Assoc J"},{"key":"key\n\t\t\t\t2018120500133927700_bib15","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamainternmed.2016.4814","article-title":"Patterns of prescription drug use before and after fragility fracture","volume":"176","author":"Munson","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t2018120500133927700_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3109\/0886022X.2015.1057800","article-title":"Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren Fail"},{"key":"key\n\t\t\t\t2018120500133927700_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ajg.2016.481","article-title":"Long-term proton pump inhibitor use is not associated with changes in bone strength and structure","volume":"112","author":"Targownik","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018120500133927700_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss","volume":"138","author":"Targownik","year":"2010","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018120500133927700_bib19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ajg.2012.200","article-title":"The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"107","author":"Targownik","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018120500133927700_bib20","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"key\n\t\t\t\t2018120500133927700_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"PRoton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t2018120500133927700_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s11255-011-9972-3","article-title":"Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report","volume":"44","author":"Yildirim","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"key\n\t\t\t\t2018120500133927700_bib23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/apt.12069","article-title":"Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia","volume":"36","author":"de Jager","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018120500133927700_bib24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018120500133927700_bib25","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018120500133927700_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t2018120500133927700_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaneurol.2015.4931","article-title":"Do proton pump inhibitors increase the risk of dementia?","volume":"73","author":"Kuller","year":"2016","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t2018120500133927700_bib28","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jgs.14956","article-title":"Proton pump inhibitors and risk of mild cognitive impairment and dementia","volume":"65","author":"Goldstein","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t2018120500133927700_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2017.06.061","article-title":"Association between proton pump inhibitor use and cognitive function in women","volume":"153","author":"Lochhead","year":"2017","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018120500133927700_bib30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/pds.1978","article-title":"Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study","volume":"19","author":"Dublin","year":"2010","journal-title":"Pharmacoepidem Drug Safe"},{"key":"key\n\t\t\t\t2018120500133927700_bib31","doi-asserted-by":"crossref","first-page":"e015735","DOI":"10.1136\/bmjopen-2016-015735","article-title":"Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans","volume":"7","author":"Xie","year":"2017","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t2018120500133927700_bib32","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0b013e31826af61a","article-title":"False alarms and pseudo-epidemics: the limitations of observational epidemiology","volume":"120","author":"Grimes","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2018120500133927700_bib33"},{"key":"key\n\t\t\t\t2018120500133927700_bib34","doi-asserted-by":"crossref","first-page":"2042533313497183","DOI":"10.1177\/2042533313497183","article-title":"Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study","volume":"4","author":"Haroon","year":"2013","journal-title":"JRSM Short Rep"},{"key":"key\n\t\t\t\t2018120500133927700_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jhm.1901","article-title":"Inappropriate prescribing of proton pump inhibitors in hospitalized patients","volume":"7","author":"Reid","year":"2012","journal-title":"J Hosp Med"},{"key":"key\n\t\t\t\t2018120500133927700_bib36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/ggi.12047","article-title":"Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board","volume":"13","author":"Jarchow-Macdonald","year":"2013","journal-title":"Geriatr Gerontol Int"},{"key":"key\n\t\t\t\t2018120500133927700_bib37","first-page":"e228","article-title":"Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting","volume":"16","author":"Heidelbaugh","year":"2010","journal-title":"Am J Manag Care"},{"key":"key\n\t\t\t\t2018120500133927700_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/001872679905200401","article-title":"Response rate in academic studies-a comparative analysis","volume":"52","author":"Baruch","year":"1999","journal-title":"Human Relations"},{"key":"key\n\t\t\t\t2018120500133927700_bib39","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/0018726708094863","article-title":"Survey response rate levels and trends in organizational research","volume":"61","author":"Baruch","year":"2008","journal-title":"Human Relations"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/dote\/article-pdf\/31\/12\/doy042\/27003710\/doy042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T21:59:38Z","timestamp":1571435978000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doy042\/5032890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,6,4]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doy042","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,6,4]]}}}